LexisNexis Patent Law Community | LexisNexis
Featured Content
  • Add content to My Page

    Select any content type from the list, once selected it will be automatically added to your 'My Page'.


    You are not logged in. Please Login to add content to your community page

01/30/2013 04:51:37 PM EST

Watson Can't Prove Rapamune Patent Invalid, Judge Says

Posted by

Law360: Intellectual Property

A Delaware federal judge on Wednesday rejected Watson Pharmaceuticals Inc.'s claims that Pfizer Inc.'s patent for the organ rejection drug Rapamune was invalid, handing Pfizer a victory in its efforts to halt abbreviated new drug applications for generic Read More...